Organoid bioprinting for vascularized tumor assembloids
Trends in Biotechnology · 2026-11 · 44 (11) · 3305-3333
DOI: 10.1016/j.tibtech.2026.04.009 ↗Kurz gefasst
Fachartikel in der Zeitschrift Trends in Biotechnology, 2026-11. Verfasst von Zhenzhen Zhou und 12 weiteren Autor:innen. Beteiligte Einrichtung: Biomanufacturing and Rapid Forming Technology Key Laboratory of Beijing Institute for Intelligent Healthcare, Key Laboratory for Advanced Materials P…. Hauptthemen laut MEDLINE: Organoids, Bioprinting, Neoplasms. Die Arbeit nennt 40 Literaturangaben. Gefördert von: Natural Science Foundation of Chongqing Municipality, Beijing Science and Technology Planning Project, Guangdong Academy of Sciences.
Abstract (Originalsprache)
The complexity and heterogeneity of the tumor microenvironment significantly influence cancer progression and therapeutic outcomes, highlighting the need for physiologically relevant in vitro models. In this study, we present vascularized tumor assembloids (VTASs) constructed via organoid bioprinting using a cell aggregate-rich living gel composed of endothelialized hepatic tumor aggregates and suspended endothelial cells. These VTASs recapitulate dense, volumetric, and hierarchical tissue architectures with functional vasculature and hepatic characteristics. Drug screening revealed reduced apoptosis and delayed intracellular drug accumulation in VTASs with dense microvasculature compared with cell-based or sparsely vascularized models, demonstrating differential responses to cisplatin, sorafenib, combination therapy, and doxorubicin. Co-culture with immune cells captured monocyte-endothelial interactions under inflammatory stimulation. Upon in vivo implantation, VTASs formed perfused tumorlike structures that recapitulated key histological and functional features of human cancer. Thus, VTASs provide a scalable and physiologically relevant platform for studying tumor biology, immune interactions, and high-throughput anticancer drug evaluation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Biomanufacturing and Rapid Forming Technology Key Laboratory of Beijing Institute for Intelligent Healthcare, Key Laboratory for Advanced Materials Processing Technology, Ministry of Education, Biomanufacturing Center,…
- National Engineering Research Center for Healthcare Devices, Guangdong Key Lab of Medical Electronic Instruments and Materials, Institute of Biological and Medical Engineering, Guangdong Academy of Sciences, Guangzhou 5…
- Institute of Industrial Science, University of Tokyo, Tokyo 153-8505, Japan.
- Department of Chemical System Engineering, Graduate School of Engineering, University of Tokyo, Tokyo 113-8656, Japan.
Förderung
- Natural Science Foundation of Chongqing Municipality
- Beijing Science and Technology Planning Project
- Guangdong Academy of Sciences
- Tsinghua University
- Beijing Nova Program
- National Key Research and Development Program of China
- Higher Education Discipline Innovation Project
- National Natural Science Foundation of China
Zitieren
APA
Zhou, Z., Pang, Y., Liao, Z., Zhou, C., Fu, M., Liu, C., Guo, Y., Yang, K., He, J., Gao, B., Shinohara, M., Sakai, Y., & Sun, W. (2026). Organoid bioprinting for vascularized tumor assembloids. Trends in Biotechnology, 44(11), 3305-3333. https://doi.org/10.1016/j.tibtech.2026.04.009
Vancouver
Zhou Z, Pang Y, Liao Z, Zhou C, Fu M, Liu C, et al. Organoid bioprinting for vascularized tumor assembloids. Trends in Biotechnology. 2026;44(11):3305-3333. doi:10.1016/j.tibtech.2026.04.009
BibTeX
@article{Zhou2026,
author = {Zhou, Zhenzhen and Pang, Yuan and Liao, Zhendong and Zhou, Chang and Fu, Meiling and Liu, Changru and Guo, Yuting and Yang, Kamto and He, Jianyu and Gao, Botao and Shinohara, Marie and Sakai, Yasuyuki and Sun, Wei},
title = {Organoid bioprinting for vascularized tumor assembloids},
journal = {Trends in Biotechnology},
year = {2026},
volume = {44},
number = {11},
pages = {3305--3333},
doi = {10.1016/j.tibtech.2026.04.009}
}
EUVIMED